<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="8169">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01826604</url>
  </required_header>
  <id_info>
    <org_study_id>22591</org_study_id>
    <nct_id>NCT01826604</nct_id>
  </id_info>
  <brief_title>Self-Retaining Retractor in Obese Patients Undergoing Cesarean Section</brief_title>
  <acronym>Alexis</acronym>
  <official_title>The Effect of a Barrier Self-Retaining Retractor in Obese Patients Undergoing Cesarean Section</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Louis University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Louis University</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the effects of the Alexis O C-section retractor
      in obese patients (BMI â‰¥30 kg/m2) who undergo Cesarean sections. Patients will be randomized
      to the use of the Alexis retractor during Cesarean section (treatment group) or the use of
      traditional hand-held retractors (control group). We will determine if there is any
      difference in surgical site infection or wound disruption rates.  We will also determine if
      there is a difference in the duration of surgery or length of time from skin incision to
      delivery of the infant, change in hemoglobin, estimated blood loss, and postoperative length
      of stay, intra-operative or postoperative anti-emetic requirements, need for hospital
      readmission or emergency room visits, or other complication rate between the two groups.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">January 2016</completion_date>
  <primary_completion_date type="Anticipated">January 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Health Services Research</study_design>
  <primary_outcome>
    <measure>Wound infection or disruption</measure>
    <time_frame>Time of surgery to 30 days post op</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>We will compare the number of patients with wound infections or disruptions when the Alexis O C-Section retractor is used vs when it is not used.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Secondary outcomes will include the differences between the two groups.</measure>
    <time_frame>From the time of surgery to 30 days post-op.</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Secondary outcomes will include the duration of surgery or length of time from skin incision to delivery of the infant, change in hemoglobin, estimated blood loss, and postoperative length of stay, intra-operative or postoperative anti-emetic requirements, need for hospital readmission or emergency room visits, or other complication rates between the two groups.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Pregnancy</condition>
  <condition>Obese</condition>
  <arm_group>
    <arm_group_label>Alexis O C-section retractor</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The Alexis O C-section retractor will be used.  Other hand-held retractors will be used as deemed necessary by the surgeon.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Conventional  hand-held surgical retractors used for C-sections will be used, including the bladder blade (Doyen retractor) and the Richardson retractor.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Alexis O C-Section Retractor</intervention_name>
    <description>The Alexis O C-section retractor will be used.  Other hand-held retractors that are deemed necessary to the surgery by the physician will also be used.</description>
    <arm_group_label>Alexis O C-section retractor</arm_group_label>
    <other_name>Alexis O C-Section Retractor</other_name>
    <other_name>C-section dual ring retractor</other_name>
    <other_name>Self retaining barrier retractor</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control- Conventional hand-held retractors</intervention_name>
    <description>Conventional hand-held retractors will be used.  A self-retaining barrier retractor will not be used.</description>
    <arm_group_label>Control</arm_group_label>
    <other_name>Doyen retractor</other_name>
    <other_name>Bladder blade</other_name>
    <other_name>Richardson retractor</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant women

          -  BMI greater than or equal to 30 kg/m squared

          -  Aged 14-50 years old

          -  Undergoing non-emergent cesarean section for delivery

        Exclusion Criteria:

          -  Subjects undergoing emergency Cesarean-section

          -  Pre-existing concurrent infection other than chorioamnionitis

          -  State of immunosuppression (ie. HIV, cancer)

          -  Long-term steroid use (&gt;2 days)

          -  Subjects with a BMI &lt;30 kg/m2
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Katherine Scolari Childress, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Louis University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Katherine Scolari Childress, M.D.</last_name>
    <phone>314-768-8873</phone>
    <email>scolarik@slu.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>St. Mary's Health Center</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63117</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Katherine Scolari  Childress, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 18, 2014</lastchanged_date>
  <firstreceived_date>April 1, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>St. Louis University</investigator_affiliation>
    <investigator_full_name>Katherine Scolari Childress, M.D.</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>cesarean section</keyword>
  <keyword>Pregnant</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
